Cadence
PrivateLast Round
Series C
Jun 23, 2026
Est. Valuation
$1.2B
Total Funding Raised
$241M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Cadence operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series C round in June 2026.
Cadence is a digital health company that provides a remote patient monitoring and virtual care platform for managing chronic conditions.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Medical AI, Health IoT, Patient Engagement, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cadence Comparables
Compare Cadence with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biofourmis | 83% | |
| OPKO Health | 79% | |
| Huma | 78% |
For institutional investors. Book with your work email.
Cadence Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 23, 2026 | ||||
| Series B | Dec 13, 2021 | ||||
| Series A | Aug 5, 2021 |
For institutional investors. Book with your work email.
Cadence Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| B Capital Group | Series C |
| B Capital Group | Series C |
| Spectrum Health Ventures | Series C |
| Thrive Capital | Series B, Series A, Series C |
| Freesolo Ventures | Series B |
| General Catalyst | Series B, Series C, Series A |
| K5 Global | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
$100M round led by Spark Capital.
- Apr 1, 2026
Serves a population of more than 100,000 patients.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- signs_new_clientOct 26, 2026
Cadence partners with Hackensack Meridian Health, Inc. to extend chronic care between visits across New Jersey, supporting more than 6,000 enrolled patients through connected devices and a clinical team.
- is_developingAug 19, 2026
FDA names Cadence as the second participant announced in Aug '26 in its Medicare-linked TEMPO digital health pilot, where the company develops AI-enabled software for hypertension management.
For institutional investors. Book with your work email.
Cadence Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cadence's valuation, stock price, and market status.
Is Cadence a public or private company?
Cadence is a private company.
What is the current stock price of Cadence?
Cadence is a private company, so its shares have no public market price. Caplight tracks Cadence's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cadence worth (valuation)?
Cadence's valuation is estimated at $1.2B based on funding round data.
Can I buy Cadence stock?
Cadence shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cadence's last funding round?
Cadence's most recent funding round was Series C on June 23, 2026.
Who are the main investors in Cadence?
Key investors in Cadence include General Catalyst, Spark Capital, Coatue Management.
Will Cadence IPO soon?
No public IPO plans have been announced for Cadence.
How can I track Cadence secondary market activity?
Caplight tracks bids, offers, and trades in Cadence's shares on secondary markets.